Clinical Trial Update: Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Sorafenib in adults with recurrent non-Hodgkin lymphoma, including Anaplastic Large Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Diffuse Large B-cell Lymphoma
• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Sorafenib (Nexavar) (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anaplastic Large Cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma | Phase 2 | Status: COMPLETED